Showing results (461-470 of 639) with videos related to
Sort By:
Pageof 64
Kyobu Geka. the Japanese Journal of Thoracic Surgery|March 16, 2016
[Cross-sectoral Approach of a Perioperative Management Center for General Thoracic Surgery]Atsushi Shimoda, Junichi Soh, Takako Ashiba, et al.Oncology Reports|October 19, 2012
Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classificationYuho Maki, Junichi Soh, Kouichi Ichimura, et al.Cancer Chemotherapy and Pharmacology|June 14, 2020
Influences of preoperative metformin on immunological factors in early breast cancerTakahiro Tsukioki, Tadahiko Shien, Takehiro Tanaka, et al.Surgical Case Reports|May 27, 2026
Tailored Management of Anomalous Systemic Arterial Supply to the Basal Segment of the Lung: A Case Report and Literature ReviewShunsuke Mori, Ken Suzawa, Koji Tomita, et al.Surgery Today|July 17, 2023
Long-term outcomes following surgical treatment for thymic epithelial tumor in Japan and an analysis of prognostic factors based on the Japanese Association for Research on the Thymus nationwide databaseMeinoshin Okumura, Ichiro Yoshino, Soichiro Funaki, et al.Journal of Cancer Research and Clinical Oncology|January 26, 2012
DNA methylation status of REIC/Dkk-3 gene in human malignanciesTatsuro Hayashi, Hiroaki Asano, Shinichi Toyooka, et al.Oncogene|December 14, 2004
Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infectionMakoto Suzuki, Shinichi Toyooka, Narayan Shivapurkar, et al.Oncology Reports|October 20, 2004
Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomasTakaya Kobatake, Masaaki Yano, Shinichi Toyooka, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Epigenetic down-regulation of death-associated protein kinase in lung cancersShinichi Toyooka, Kiyomi O Toyooka, Kuniharu Miyajima, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological featuresRiichiroh Maruyama, Shinichi Toyooka, Kiyomi O Toyooka, et al.Pageof 64